-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
From November 10th to 11th, the drug regulatory bureaus of Guangdong and Qinghai provinces issued drug random inspection information notices.
The details are as follows:
Announcement of Guangdong Drug Administration on Drug Sampling Inspection Information (No.
Announcement of Guangdong Drug Administration on Drug Sampling Inspection Information (No.
notice
No.
In order to strengthen the supervision of drug quality and ensure the safety of drug use by the public, according to the 2021 Guangdong Drug Sampling Inspection Plan, the Guangdong Drug Supervision and Administration Bureau organized random drug quality inspections on drug production and operation enterprises and medical institutions across the province
1.
Recently, a total of 1821 batches of drugs of 918 varieties from 64 drug manufacturers, 489 drug distributors and 190 medical institutions have been sampled across the province
After verification and confirmation, the current sampling information is announced as follows: 911 varieties of 1813 batches have been tested and meet the drug standards
2.
The Guangdong Provincial Drug Administration requires relevant enterprises and units to take risk control measures such as suspension of sales and use, recalls, etc.
3.
The Guangdong Provincial Drug Administration reminds consumers to purchase drugs in legal and formal medical institutions, pharmacies, etc.
List of unqualified drugs
Qinghai Province Drug Quality Sampling Inspection Information Announcement (Phase 2 of 2021)
Qinghai Province Drug Quality Sampling Inspection Information Announcement (Phase 2 of 2021)No.
No.
1.
A total of 39 batches of drugs in 32 varieties from 16 drug manufacturers were randomly inspected in this period
2.
Investigation and handling of substandard drugs
This issue does not involve the investigation of substandard drugs
.
3.
Reminders on safe consumption of medicines
The Qinghai Provincial Drug Administration reminds consumers: Residents should follow the doctor’s advice and purchase prescription drugs with a prescription issued by a practicing physician or assistant physician; please purchase drugs from legal and regular medical institutions, pharmacies, etc.
; when purchasing drugs, please request and keep them valid For bills, carefully check the relevant markings of the outer packaging of the drug, such as whether the date of manufacture, expiration date, manufacturer, approval number, etc.
are complete, and whether it is within the validity period; if necessary, you can log on to the National Medical Products Administration (NMPA) website (https: // basic database query and verification of drug registration related information; after purchasing drugs, the drugs should be stored in accordance with the storage conditions indicated in the instructions, and the drugs should be taken according to the doctor's instructions or usage and dosage, paying special attention to the adverse reactions on the instructions content contraindications, and precautions
.
Consumers are welcome to actively participate in the social co-treatment of drug safety.
If you purchase counterfeit, inferior or substandard drugs, please call the local market supervision department to report complaints at 12315
.